Share chart ObsEva SA
Extended chart
Simple chart
About ObsEva SA
ObsEva SA, биофармацевтическая компания, работающая на клинической стадии, специализируется на разработке и коммерциализации новых терапевтических средств для женщин, страдающих репродуктивным здоровьем и беременных. Компания разрабатывает Linzagolix, пероральный антагонист рецепторов гонадотропин-рилизинг-гормона для лечения боли, связанной с эндометриозом, и обильных менструальных кровотечений, связанных с миомой матки у женщин в пременопаузе. more detailsMain settings
| IPO date | 2017-01-26 |
|---|---|
| ISIN | CH0346177709 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | link |
| Change price per day: | 0% (0.084) |
|---|---|
| Change price per week: | 0% (0.084) |
| Change price per month: | 0% (0.084) |
| Change price per 3 month: | 0% (0.084) |
| Change price per half year: | 0% (0.084) |
| Change price per year: | 0% (0.084) |
| Change price per 3 year: | -95.71% (1.96) |
| Change price per 5 year: | -97.96% (4.12) |
| Change price per year to date: | 0% (0.084) |
Grade
Underestimation
| Title | Value | Grade |
|---|---|---|
| P/S | 0.694 | 10 |
| P/BV | 1.61 | 8 |
| P/E | 0 | 0 |
Efficiency
| Title | Value | Grade |
|---|---|---|
| ROA, % | -56.62 | 0 |
| ROE, % | -146.39 | 0 |
| ROIC, % | -68.03 | 0 |
Dividends
| Title | Value | Grade |
|---|---|---|
| Dividend yield | 0 | 0 |
| DSI | 0 | 0 |
| Average dividend growth | 0 | 0 |
Debt
| Title | Value | Grade |
|---|---|---|
| Debt/EBITDA | -0.1987 | 10 |
| Debt/Ratio | 0.1818 | 10 |
| Debt/Equity | 0.9643 | 9 |
Growth impulse
| Title | Value | Grade |
|---|---|---|
| Yield Revenue, % | 115194.12 | 10 |
| Yield Ebitda, % | -87.96 | 0 |
| Yield EPS, % | -86.97 | 0 |
Main owners
| Institutions | Volume | Share, % |
|---|---|---|
| Sofinnova Investments, Inc. | 4 749 623 | 4.37 |
| NEA Management Company, LLC | 4 586 563 | 4.22 |
| Credit Suisse Ag/ | 1 750 573 | 1.61 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 668 485 | 0.62 |
| Pictet Asset Management SA | 363 772 | 0.33 |
| Cutter & Co. Brokerage, Inc. | 201 200 | 0.19 |
| Virtu Financial LLC | 109 073 | 0.1 |
| Abingworth, LLP | 87 999 | 0.08 |
| Geode Capital Management, LLC | 82 227 | 0.08 |
| SIMPLEX TRADING, LLC | 69 860 | 0.06 |
Similar companies
P/E & P/BV
Company management
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Fabien Lefebvre de Ladonchamps | Chief Admin. Officer | N/A | 1979 (46 years) |
| Ms. Delphine Renaud | Personal Assistant to the CSO and Head of R&D | N/A | |
| Mr. William Michael Brown | Chief Financial Officer | N/A | 1983 (42 years) |
| Dr. Ernest Loumaye M.D., OB/GYN, Ph.D. | Co-Founder & Director | 62k | 1952 (73 years) |
| Mr. Brian O'Callaghan | CEO & Director | 1969 (56 years) | |
| Mr. Clive Bertram | Chief Commercial Officer | 1968 (57 years) | |
| Mr. Luigi Marro | Chief Transformation Officer | 1966 (59 years) | |
| Ms. Katja Buhrer | Chief Strategy Officer | 1982 (43 years) | |
| Ms. Brandi Howard Ph.D. | Chief Clinical Officer |
About company
Address: Switzerland, Geneva, Chemin des Aulx 12 - Open in google maps, Open in yandex maps
Website: http://www.obseva.com
Website: http://www.obseva.com
